Table 2.
Age groups | N | eGFR ± SD | eGFR < 60% (N) | eGFR < 60 (DM-HTN-) % (N) | eGFR < 60 (DM-HTN-Prot ≤ 1 +) % (N) |
---|---|---|---|---|---|
All subjects | 17,329 | 99 ± 22 | 5.3 (1415) | 1.5 (360) | 1.5 (351) |
20–39 | 3126 | 115 ± 13 | 0.20 (8) | 0.19 (7) | 0.18 (6) |
40–49 | 3333 | 102 ± 15 | 0.81 (23) | 0.30 (8) | 0.30 (8) |
50–59 | 3758 | 94 ± 15 | 2.6 (84) | 0.70 (21) | 0.66 (19) |
60–69 | 4220 | 82 ± 25 | 12.2 (437) | 3.4 (104) | 3.4 (103) |
≥ 70 | 2892 | 68 ± 26 | 32.7 (863) | 8.8 (220) | 8.7 (215) |
< 70 | 14,437 | 102 ± 20 | 2.6 (552) | 0.78 (140)* | 0.75 (136)** |
All men | 7291 | 98 ± 19 | 4.1 (573) | 1.1 (148) | 1.09 (143) |
20–39 | 1284 | 113 ± 9 | 0.08 (3) | 0.05 (2) | 0.05 (2) |
40–49 | 1321 | 101 ± 12 | 0.67 (9) | 0.23 (3) | 0.22 (3) |
50–59 | 1527 | 93 ± 13 | 3.4 (42) | 0.98 (9) | 0.94 (8) |
60–69 | 1853 | 82 ± 23 | 8.8 (175) | 2.0 (41) | 2.0 (41) |
≥ 70 | 1306 | 69 ± 25 | 25.1 (344) | 7.0 (93) | 6.8 (89) |
< 70 | 5985 | 101 ± 17 | 2.2 (229) | 0.59 (55)* | 0.57 (54)** |
All women | 10,038 | 99 ± 25 | 6.5 (842) | 1.9 (212) | 1.8 (208) |
20–39 | 1842 | 116 ± 15 | 0.32 (5) | 0.32 (5) | 0.30 (4) |
40–49 | 2012 | 102 ± 18 | 0.94 (14) | 0.37 (5) | 0.37 (5) |
50–59 | 2231 | 94 ± 17 | 1.9 (42) | 0.44 (12) | 0.39 (11) |
60–69 | 2367 | 82 ± 27 | 15.3 (262) | 4.7 63) | 4.6 (62) |
≥ 70 | 1586 | 67 ± 26 | 38.4 (519) | 10.1 (127) | 10.1 (126) |
< 70 | 8452 | 103 ± 23 | 2.9 (323) | 0.95 (85)* | 0.91(82)** |
N = number within group; % = adjusted percent-probability weighted for the registered 2014 Thai population stratified by age, sex, area of residence (urban/rural), geographic region; eGFR < 60, decreased GFR-all causes; eGFR < 60 (DM-HT-), decreased GFR without diabetes or hypertension; eGFR < 60(DM-HT-Prot ≤ 1 +), decreased GFR without diabetes, hypertension or heavy proteinuria.
*CKDu1; ***CKDu2.